Rare primary immunodeficiencies, severe congenital neutropenia, WHIM Syndrome
X4 Pharmaceuticals, Inc. has partnered with Invitae to offer third-party sponsored genetic testing at no charge for individuals who may carry a genetic mutation known to be associated with severe chronic and/or congenital neutropenia (SCN), including WHIM syndrome.
SCN consists of a heterogeneous group of rare hematological diseases characterized by a selective decrease in circulating neutrophils, impaired maturation or trafficking, and higher risk of recurrent severe infections.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.